Platform
Features
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Employees
Links
Kenneth Galbraith
53 members
18 members
6 members
14 members
8 members
5 members
View all
Oxford Nanopore Technologies
8 followers
TG Therapeutics
1 follower
Ada
14 followers
AIMCo
11 followers
Architecture49
5 followers
Voyager Therapeutics
StackAdapt
35 followers
Visier
19 followers
Verafin
·¡¾±»å´Ç²õ-²Ñ´Ç²Ô³Ù°ùé²¹±ô
OPTrust
Explore companies